Phytochemicals: Target-Based Therapeutic Strategies for Diabetic Retinopathy
- PMID: 29937497
- PMCID: PMC6100391
- DOI: 10.3390/molecules23071519
Phytochemicals: Target-Based Therapeutic Strategies for Diabetic Retinopathy
Abstract
Background: A variety of causative factors are involved in the initiation of diabetic retinopathy (DR). Current antidiabetic therapies are expensive and not easily accessible by the public. Furthermore, the use of multiple synthetic drugs leads to severe side effects, which worsen the diabetic patient’s condition. Medicinal plants and their derived phytochemicals are considered safe and effective treatment and their consumption can reduce the DR risk. In this article, we discuss a variety of medicinal plants, and their noteworthy bio-active constituents, that will be utilized as target based therapeutic strategies for DR. Methods: A broad-spectrum study was conducted using published English works in various electronic databases including Science Direct, PubMed, Scopus, and Google Scholar. Results: Targeting the multiple pathological factors including ROS, AGEs formation, hexosamine flux, PARP, PKC, and MAPK activation through variety of bioactive constituents in medicinal plants, diabetes progression can be delayed with improved loss of vision. Conclusions: Data reveals that traditional herbs and their prominent bioactive components control and normalize pathological cellular factors involved in DR progression. Therefore, studies should be carried out to explore the protective retinopathy effects of medicinal plants using experimental animal and humans models.
Keywords: advanced glycation end-products; aldose reductase; diabetic retinopathy; metalloproteinase-9; mitogen-activated protein kinases; oxidative stress; phytochemicals; poly (ADP-ribose) polymerase; protein kinase C; reactive oxygen species; vascular endothelial growth factor.
Conflict of interest statement
There is no conflict of interest among authors.
Figures




Similar articles
-
Bioactive phytochemicals that regulate the cellular processes involved in diabetic nephropathy.Phytomedicine. 2018 Jan 15;39:146-159. doi: 10.1016/j.phymed.2017.12.018. Epub 2017 Dec 18. Phytomedicine. 2018. PMID: 29433676 Review.
-
Aldose reductase / polyol inhibitors for diabetic retinopathy.Curr Pharm Biotechnol. 2011 Mar 1;12(3):373-85. doi: 10.2174/138920111794480642. Curr Pharm Biotechnol. 2011. PMID: 20939801 Review.
-
Association between miRNAs expression and signaling pathways of oxidative stress in diabetic retinopathy.J Cell Physiol. 2019 Jun;234(6):8522-8532. doi: 10.1002/jcp.27801. Epub 2018 Nov 27. J Cell Physiol. 2019. PMID: 30478922 Review.
-
Management of diabetic complications: a chemical constituents based approach.J Ethnopharmacol. 2013 Oct 28;150(1):51-70. doi: 10.1016/j.jep.2013.08.051. Epub 2013 Sep 13. J Ethnopharmacol. 2013. PMID: 24041460 Review.
-
Glucose transport, transporters and metabolism in diabetic retinopathy.Biochim Biophys Acta Mol Basis Dis. 2024 Mar;1870(3):166995. doi: 10.1016/j.bbadis.2023.166995. Epub 2023 Dec 22. Biochim Biophys Acta Mol Basis Dis. 2024. PMID: 38142757 Review.
Cited by
-
Kuwanon G protects HT22 cells from advanced glycation end product-induced damage.Exp Ther Med. 2021 May;21(5):425. doi: 10.3892/etm.2021.9869. Epub 2021 Feb 25. Exp Ther Med. 2021. PMID: 33747164 Free PMC article.
-
Inhibition of Aldose Reductase by Novel Phytocompounds: A Heuristic Approach to Treating Diabetic Retinopathy.Evid Based Complement Alternat Med. 2022 Mar 21;2022:9624118. doi: 10.1155/2022/9624118. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35356240 Free PMC article.
-
A New Oleanane Type Saponin from the Aerial Parts of Nigella sativa with Anti-Oxidant and Anti-Diabetic Potential.Molecules. 2020 May 6;25(9):2171. doi: 10.3390/molecules25092171. Molecules. 2020. PMID: 32384790 Free PMC article.
-
Silymarin reduces retinal microvascular damage in streptozotocin-induced diabetic rats.Sci Rep. 2022 Sep 23;12(1):15872. doi: 10.1038/s41598-022-20297-2. Sci Rep. 2022. PMID: 36151457 Free PMC article.
-
Potential Roles of Anti-Inflammatory Plant-Derived Bioactive Compounds Targeting Inflammation in Microvascular Complications of Diabetes.Molecules. 2022 Oct 29;27(21):7352. doi: 10.3390/molecules27217352. Molecules. 2022. PMID: 36364178 Free PMC article. Review.
References
-
- Roglic G. WHO Global report on diabetes: A summary. Int. J. Noncommun. Dis. 2016;1:3–8. doi: 10.4103/2468-8827.184853. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical